(Q45862905)

17 December 2017

title

The lithiumeter: a measured approach (English)

1 reference

17 December 2017

1

Gin S Malhi

1 reference

17 December 2017

author name string

Michelle Tanious

series ordinal

2

1 reference

17 December 2017

Samuel Gershon

series ordinal

3

1 reference

17 December 2017

publication date

1 May 2011

1 reference

17 December 2017

published in

Bipolar Disorders

1 reference

17 December 2017

volume

13

1 reference

17 December 2017

issue

3

1 reference

17 December 2017

page(s)

219-226

1 reference

17 December 2017

What is a mood stabilizer?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium specificity in bipolar illness: a classic agent for the classic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

A critical appraisal of lithium's efficacy and effectiveness: the last 60 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium effects: relation to lithium dose and to plasma peak levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium and the kidney: an updated review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Differential pharmacokinetics of lithium in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Effects of lithium treatment on hypothalamic-pituitary-thyroid axis: a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium-associated clinical hypothyroidism. Prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium therapy and hyperparathyroidism: an evidence-based assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

The management of individuals with bipolar disorder: a review of the evidence and its integration into clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Prophylactic therapy with lithium in elderly patients with unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Assessment and treatment of bipolar disorder in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Clinical manifestations and management of acute lithium intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Clinical relevance of drug interactions with lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Sex differences in response to lithium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Women with bipolar illness: clinical and research issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Is lithium in a class of its own? A brief profile of its clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium: updated human knowledge using an evidence-based approach: Part I: Clinical efficacy in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium in mood disorders: increasing evidence base, declining use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium in psychiatric therapy and prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Is polarity of recurrence related to serum lithium level in patients with bipolar disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Clinical factors associated with treatment noncompliance in euthymic bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Implication of serum concentration monitoring in patients with lithium intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Review of lithium effects on brain and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Lithium toxicity: an iatrogenic problem in susceptible individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

A reevaluation of risk of in utero exposure to lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-5618.2011.00918.X

10.1111/J.1399-5618.2011.00918.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017